Skip to main content

Selected Grants


EFC17801_9085-0205 SANOFI Pro00113681

Clinical TrialPrincipal Investigator · Awarded by Sanofi US · 2024 - 2028

Lung Transplant Clinical Trial Network (LT-CTN)

ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2028

Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026

Long Term Follow up of the Lung Transplant Outcomes Group Cohort

ResearchCo Investigator · Awarded by University of Pennsylvania · 2019 - 2026

EFC17801_9085-0205 SANOFI Pro00113681

Clinical TrialPrincipal Investigator · Awarded by Sanofi US · 2024 - 2028

Lung Transplant Clinical Trial Network (LT-CTN)

ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2028

Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2022 - 2026

Long Term Follow up of the Lung Transplant Outcomes Group Cohort

ResearchCo Investigator · Awarded by University of Pennsylvania · 2019 - 2026

Secondary Analyses to Support the Rational Design of Clinical Trials in Chronic Lung Allograft Dysfunction

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025

Evaluating PFT trends for the development of Baseline Lung Allograft Dysfunction after lung transplantation

ResearchCollaborator · Awarded by International Society for Heart & Lung Transplantation · 2024 - 2024

Club cell secretory protein to distinguish chronic allograft dysfunction risk in lung transplant recipients

ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2023 - 2024

CTOT Long-Term Extension Study

ResearchCo Investigator · Awarded by Cystic Fibrosis Foundation · 2019 - 2024

Early Posttransplant Intragraft Hyaluronan as an Independent Biomarker of CLAD Risk

ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2022 - 2024

Chronic Lung Allograft Dysfunction

ResearchCo Investigator · Awarded by AstraZeneca AB · 2019 - 2023

Genetics of Acute Rejection and Chronic Lung Allograft Dysfunction

ResearchCo Investigator · Awarded by Cystic Fibrosis Foundation · 2019 - 2022

Club Cells and CCSP in the pathogenesis of CLAD/spatial transcriptomics

ResearchCo Investigator · Awarded by Icahn School of Medicine at Mount Sinai · 2020 - 2021

Hyaluronan in Acute Rejection and Chronic Allograft Dysfunction after Lung Transplantation - CTOT Ancillary

ResearchPrincipal Investigator · Awarded by Mount Sinai School of Medicine · 2019 - 2021

Lung Tissue Gene Expression Profiling in Chronic Lung Allograft Dysfunction-CTOT

ResearchPrincipal Investigator · Awarded by Mount Sinai School of Medicine · 2018 - 2019

CTOT Ancillary Studies Fund Carry Forward BAL

ResearchCo-Principal Investigator · Awarded by Mount Sinai School of Medicine · 2016 - 2017

Hyaluronan in Acute Rejection and Chronic Lung Allograft Dysfunction after Human Lung Transplantation

ResearchPrincipal Investigator · Awarded by Mount Sinai School of Medicine · 2016 - 2017

CTOT - Cell Free DNA

ResearchCollaborator · Awarded by Mount Sinai School of Medicine · 2016 - 2017

CTOT Ancillary Studies Fund

ResearchCo-Principal Investigator · Awarded by Mount Sinai School of Medicine · 2014 - 2016

Blood-SCAN feasibility Phase 3

ResearchPrincipal Investigator · Awarded by Harvard Pilgrim Health Care, Inc. · 2013 - 2016

External Relationships


  • Avalyn
  • Sanofi
  • Theravance, Inc

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.